This Denali Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Friday

Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• William Blair analyst Andy Hsieh initiated coverage on Elevation Oncology, Inc. ELEV with an Outperform rating. Elevation Oncology shares closed at $0.5951 on Thursday. See how other analysts view this stock.
• William Blair analyst Sarah Schram initiated coverage on Denali Therapeutics Inc. DNLI with an Outperform rating. Denali Therapeutics shares closed at $20.84 on Thursday. See how other analysts view this stock.

Considering buying DNLI stock? Here’s what analysts think:

Read This Next:

• How To Earn $500 A Month From KB Home Stock Ahead Of Q4 Earnings